SPAC227.03c Antibody

What is SPAC227.03c and why is it studied in fission yeast research?

SPAC227.03c (yea6) is a gene in Schizosaccharomyces pombe with potential involvement in mitochondrial function. It has been identified in systematic screens examining cell cycle control and mitochondrial metabolism . The gene product shows homology to S. cerevisiae NDT1 and NDT2, which are involved in pyridine nucleotide transport. Research indicates it may participate in exogenous NADH oxidation processes that can result in uncoupling of mitochondrial respiration . Antibodies against this protein are valuable tools for studying its expression, localization, and function in cellular processes, particularly in mitochondrial bioenergetics research.

What validation methods should be used for SPAC227.03c antibodies?

Antibodies targeting SPAC227.03c should undergo rigorous validation using multiple complementary approaches:

• Western blotting with positive and negative controls:

  • Positive controls: Extracts from wild-type S. pombe strains

  • Negative controls: Extracts from SPAC227.03c deletion mutants (SPAC227.03c∆)

  • Expected outcome: Single band of predicted molecular weight in wild-type, absent in deletion strain

• Immunofluorescence validation:

  • Compare localization patterns between wild-type and deletion strains

  • Examine co-localization with known mitochondrial markers

  • Test specificity using peptide competition assays

• Recombinant protein reactivity testing:

  • Assess antibody reactivity against purified recombinant SPAC227.03c protein

  • Determine detection threshold and linear range of quantification

• Cross-reactivity assessment:

  • Test against related proteins in S. pombe and other yeast species

  • Evaluate potential cross-reactivity with human proteins if using in comparative studies

Similar validation approaches have been successfully employed for other yeast proteins and can be adapted from established antibody validation protocols for immunohistochemistry and immunoblotting applications .

How should I design immunofluorescence experiments to study SPAC227.03c localization?

For optimal immunofluorescence experiments targeting SPAC227.03c:

• Sample preparation:

  • Fix cells with 4% formaldehyde for 30 minutes at room temperature

  • For improved antigen accessibility, consider mild cell wall digestion with zymolyase (0.5 mg/ml, 10 minutes)

  • Permeabilize with 0.1% Triton X-100 for 10 minutes

• Antibody incubation:

  • Primary antibody dilution: Start with 1:50-1:200 (optimize based on specific antibody)

  • Secondary antibody selection: Use highly cross-adsorbed fluorescent conjugates

  • Include counterstains for nuclei (DAPI) and relevant organelles

• Essential controls:

  • SPAC227.03c deletion strain (negative control)

  • Secondary antibody-only control

  • Peptide competition control

  • Co-staining with mitochondrial markers (based on predicted localization)

• Imaging parameters:

  • Capture z-stacks to ensure complete cellular visualization

  • Maintain identical acquisition settings across experimental conditions

  • Use appropriate spectral separation to avoid bleed-through

This approach follows established protocols for immunolocalization studies in yeast and should be optimized for the specific antibody characteristics .

What experimental design is recommended for studying SPAC227.03c expression during the cell cycle?

To effectively study SPAC227.03c expression throughout the cell cycle:

• Synchronization options:

  • Nitrogen starvation and release

  • Temperature-sensitive cdc mutants (e.g., cdc25-22)

  • Lactose gradient centrifugation

  • Hydroxyurea block and release

• Sample collection:

  • Collect samples at 15-20 minute intervals for at least one full cell cycle

  • Process parallel samples for protein extraction and microscopy

  • Include cell cycle markers for verification (e.g., septation index)

• Expression analysis methods:

  • Western blot with quantification normalized to loading control

  • Quantitative immunofluorescence microscopy

  • Consider RNA-seq for transcriptional profiling

• Controls and validation:

  • Include asynchronous cultures as reference

  • Verify synchrony using established cell cycle markers

  • Compare protein and transcript levels to identify post-transcriptional regulation

This methodology builds on established approaches for cell cycle studies in S. pombe and can be adapted for specific research questions regarding SPAC227.03c regulation .

How can I optimize immunoprecipitation protocols for SPAC227.03c interaction studies?

For successful immunoprecipitation (IP) of SPAC227.03c and identification of interaction partners:

• Cell lysis optimization:

  • Buffer composition: 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100

  • For mitochondrial proteins: Include 0.1% digitonin or 0.5% CHAPS

  • Add protease inhibitors, phosphatase inhibitors, and 1 mM DTT

  • For putative membrane-associated proteins, consider crosslinking before lysis

• IP procedure:

  • Pre-clear lysates with protein A/G beads (1 hour, 4°C)

  • Incubate with 2-5 μg antibody per mg of protein (overnight, 4°C)

  • Capture with magnetic protein A/G beads (2 hours, 4°C)

  • Wash 5× with decreasing salt concentrations

• Controls and validation:

  • Input control (5-10% of starting material)

  • IgG control (matched isotype)

  • Reverse IP with identified partners

  • SPAC227.03c deletion strain as negative control

• Detection methods:

  • Western blotting for known or suspected partners

  • Mass spectrometry for unbiased interaction discovery

  • Consider SILAC or TMT labeling for quantitative comparison

This approach draws from established protocols for yeast protein interaction studies and can be modified based on specific experimental needs and antibody characteristics .

What techniques can be employed to study SPAC227.03c function in mitochondrial metabolism?

To investigate SPAC227.03c's role in mitochondrial metabolism, consider these advanced approaches:

• Respirometry in permeabilized cells:

  • Selectively permeabilize plasma membranes while preserving mitochondrial integrity

  • Measure oxygen consumption with various substrates (pyruvate, succinate, etc.)

  • Compare wild-type and SPAC227.03c∆ strains under different metabolic conditions

• Metabolic flux analysis with 13C-labeled substrates:

  • Culture cells with 13C-labeled glucose or other carbon sources

  • Analyze metabolite labeling patterns by GC-MS or LC-MS

  • Construct metabolic network models to determine flux distributions

• In situ mitochondrial assays:

  • Measure membrane potential using potential-sensitive dyes (TMRM, JC-1)

  • Assess ROS production with specific probes

  • Monitor NAD+/NADH ratios using fluorescent biosensors

• Genetic interaction studies:

  • Create double mutants with known mitochondrial transporters

  • Perform synthetic genetic array (SGA) analysis

  • Conduct epistasis analysis with related pathway components

This experimental strategy is supported by established approaches in yeast mitochondrial research, including selective membrane permeabilization for in situ studies and 13C metabolic flux analysis for in vivo investigations .

How can I address inconsistent detection of SPAC227.03c in immunoblotting experiments?

When facing inconsistent SPAC227.03c detection in Western blots, consider these methodological solutions:

• Sample preparation optimization:

  • For membrane-associated proteins: Use gentle detergents (0.5% DDM or 1% digitonin)

  • Include reducing agents (5 mM DTT or 10 mM β-mercaptoethanol)

  • Avoid sample heating above 70°C if protein aggregation is suspected

  • Consider specialized extraction methods for mitochondrial proteins

• Antibody optimization:

  • Titrate antibody concentration (typical range: 0.04-0.4 μg/mL)

  • Extend primary antibody incubation (overnight at 4°C)

  • Test different blocking agents (5% BSA often superior to milk for phospho-proteins)

  • Consider enhanced detection systems (fluorescent secondary antibodies or high-sensitivity chemiluminescence)

• Protocol modifications:

  • Transfer conditions: Optimize voltage/amperage for proteins of specific molecular weight

  • Membrane selection: PVDF for general use, nitrocellulose for low background

  • Increase exposure time or use gradient exposure series

  • For low abundance proteins, enrich through fractionation or immunoprecipitation

• Validation approaches:

  • Test multiple antibody clones if available

  • Include positive controls (overexpression constructs)

  • Verify specificity with knockout/knockdown samples

  • Consider epitope tags if native protein detection remains challenging

This troubleshooting guide draws from established protocols for challenging Western blotting applications and incorporates optimization strategies used for other yeast proteins .

How should I interpret differences in SPAC227.03c detection between immunohistochemical assays using different antibody clones?

When different antibody clones yield discrepant results in SPAC227.03c detection:

• Systematic comparison approach:

  • Create a standardized testing panel with identical positive and negative controls

  • Document detailed staining patterns and intensity scores

  • Compare different fixation methods and antigen retrieval protocols

  • Analyze results using quantitative image analysis when possible

• Potential reasons for discrepancies:

  • Epitope accessibility: Different epitopes may be differentially exposed in fixed tissues

  • Clone sensitivity: Antibodies may have different detection thresholds (illustrated by SP142 vs. 22C3 comparison for PD-L1)

  • Specificity differences: Clones may have different cross-reactivity profiles

  • Technical variables: Staining platforms, detection systems, and protocols impact results

• Resolution strategies:

  • Employ multiple clones targeting different epitopes

  • Validate with orthogonal methods (Western blot, RNA expression)

  • Conduct peptide competition assays to confirm specificity

  • Consider the biological question when selecting the most appropriate clone

• Interpretation framework:

  • Document clone-specific staining patterns

  • Set clone-specific positivity thresholds

  • Consider reporting results from multiple antibodies

  • Interpret biological significance in context of validation data

This interpretation framework draws from lessons learned in clinical immunohistochemistry, where different antibody clones can yield significantly different results and require standardized validation approaches .

How can SPAC227.03c antibodies be integrated into multi-omics experimental designs?

For integrating SPAC227.03c antibody-based assays into multi-omics experimental designs:

• Coordinated sample preparation:

  • Divide cell cultures for parallel processing:

    • Protein extraction for immunoblotting and IP-MS

    • RNA isolation for transcriptomics

    • Fixation for immunofluorescence microscopy

    • Metabolite extraction for metabolomics

• Temporal experimental design:

  • Implement time-course sampling for dynamic studies

  • Align sampling points across all assay types

  • Consider sequential extraction protocols to maximize data from limited samples

• Data integration approaches:

  • Correlate protein abundance (antibody-based) with transcript levels

  • Map protein localization data to interaction networks

  • Integrate with temporal clustering of gene expression profiles using tools like MFUZZanalysis()

  • Apply factorial analysis methods like PCA and clustering with HCPCanalysis()

• Validation and quality control:

  • Include shared controls across all platforms

  • Implement batch correction methods

  • Verify key findings using orthogonal approaches

  • Account for temporal delays between transcription and translation

This approach leverages strategies from integrated multi-omics studies and can be adapted based on specific research questions regarding SPAC227.03c function .

What methods can be used to study post-translational modifications of SPAC227.03c?

To investigate post-translational modifications (PTMs) of SPAC227.03c:

• Phosphorylation analysis:

  • Immunoprecipitate SPAC227.03c under native conditions

  • Detect phosphorylation using:

    • Phospho-specific antibodies (if available)

    • Phos-tag SDS-PAGE for mobility shift detection

    • LC-MS/MS analysis after phosphopeptide enrichment

  • Compare modifications under different conditions (nutrient stress, cell cycle phases)

• Ubiquitination and SUMOylation:

  • Co-IP experiments with tagged ubiquitin/SUMO constructs

  • Use deubiquitinase inhibitors in lysis buffers

  • Detect modified forms by Western blot with size shift analysis

  • Verify with mass spectrometry to identify exact modification sites

• Other potential modifications:

  • Acetylation: Immunoprecipitate with anti-acetyl-lysine antibodies

  • Glycosylation: Detect with glycan-specific lectins or glycosidase treatments

  • Proteolytic processing: N-terminal sequencing of protein fragments

• Functional significance assessment:

  • Generate mutants at identified modification sites

  • Assess impact on protein localization, stability, and function

  • Determine effect on known protein-protein interactions

  • Correlate modifications with stress responses or cell cycle progression

This methodological approach incorporates established protocols for studying protein modifications and can be tailored based on the specific biology of SPAC227.03c .

How can SPAC227.03c antibodies be used in comparative studies with other yeast species?

For cross-species comparative studies using SPAC227.03c antibodies:

• Cross-reactivity assessment:

  • Test antibody reactivity against:

    • Close relatives (S. japonicus, S. octosporus)

    • Distant relatives (S. cerevisiae, C. albicans)

    • Recombinant orthologs from each species

  • Create epitope alignment maps to predict cross-reactivity

• Optimization for different species:

  • Adjust extraction protocols based on cell wall differences

  • Modify antibody concentrations and incubation conditions

  • Consider species-specific fixation requirements for microscopy

• Experimental design for evolutionary studies:

  • Compare protein expression levels across species under identical conditions

  • Assess subcellular localization conservation

  • Investigate functional complementation across species

  • Document species-specific protein-protein interactions

• Data interpretation framework:

  • Account for protein sequence divergence in analyses

  • Consider species-specific cell biology when interpreting localization

  • Use orthogonal approaches to verify critical findings

  • Interpret within evolutionary context of mitochondrial function

This approach builds on established methods for cross-species protein studies and can provide valuable insights into the evolution of SPAC227.03c function across different yeast lineages .

What experimental approaches can determine if SPAC227.03c functionally interacts with telomere maintenance mechanisms?

To investigate potential functional interactions between SPAC227.03c and telomere maintenance:

• Genetic interaction studies:

  • Create double mutants with known telomere regulators (e.g., taz1∆, SPAC227.03c∆)

  • Assess synthetic phenotypes (growth, viability, chromosome stability)

  • Perform epistasis analysis to determine pathway relationships

  • Use temperature-sensitive alleles for essential interaction partners

• Telomere length and integrity assays:

  • Southern blot analysis of telomere length in wild-type vs. SPAC227.03c∆

  • Telomere restriction fragment (TRF) analysis

  • Chromosome end protection assays (detection of end fusions)

  • In situ hybridization to visualize telomere clustering

• Cell cycle and telomere entanglement studies:

  • Live cell imaging with tagged telomere components

  • Analysis of RPA localization at telomeres

  • Assessment of entanglement resolution during mitosis

  • Evaluation of nuclear envelope dynamics in relation to telomere function

• Mechanistic investigations:

  • Co-immunoprecipitation with telomere-associated proteins

  • Analysis of post-translational modifications in response to telomere stress

  • Examination of recruitment to damaged telomeres

  • Investigation of potential roles in DNA replication fork stability at telomeres

This experimental strategy draws from established approaches used to study telomere entanglements and their resolution in fission yeast .

How might affinity maturation techniques be applied to enhance SPAC227.03c antibody performance?

Affinity maturation could substantially improve SPAC227.03c antibody performance through these advanced approaches:

• Structure-based optimization:

  • Generate 3D models of antibody-antigen complexes

  • Identify key interaction residues via computational analysis

  • Design targeted mutations in complementarity-determining regions (CDRs)

  • Test mutants systematically using binding assays

  • Measure improvements using surface plasmon resonance (SPR)

• Experimental screening methods:

  • Implement phage display with error-prone PCR to generate variant libraries

  • Perform molecular dynamics (MD) simulations to predict binding improvements

  • Use structure-guided approaches to introduce specific mutations

  • Apply binding free energy calculations (MM/PBSA) to predict affinity changes

• Validation and characterization:

  • Compare wild-type and affinity-matured antibodies using:

    • Enzyme-linked immunosorbent assay (ELISA)

    • Surface plasmon resonance (SPR)

    • Bio-layer interferometry (BLI)

  • Assess improvements in specificity, sensitivity, and signal-to-noise ratio

  • Validate enhanced performance in application-specific contexts

• Specific optimization targets:

  • S103F/Y mutation in HCDR-3 and S33R mutation in LCDR-1 (based on successful examples)

  • Introduction of additional hydrogen-bonding, hydrophobic interactions, or salt-bridges

  • Formation of triple tandem formats for enhanced avidity

This approach draws from successful antibody engineering strategies documented in the literature, including significant affinity enhancements achieved through rational design and computational approaches .

What new insights could be gained from studying SPAC227.03c in the context of cell cycle control?

Investigating SPAC227.03c in the context of cell cycle control could reveal novel insights through these approaches:

• Cell cycle-specific expression and localization:

  • Precise quantification of protein levels throughout the cell cycle

  • High-resolution time-lapse imaging of tagged SPAC227.03c

  • Correlation with mitochondrial dynamics during division

  • Investigation of potential cell cycle-dependent post-translational modifications

• Genetic interaction mapping:

  • Synthetic genetic array analysis with cell cycle regulators

  • Focus on G2/M transition regulators identified in systematic screens

  • Assess genetic interactions with stress-nutritional response (SR) and cell geometry sensing (CGS) pathways

  • Investigate connections to CDK Tyr15 phosphorylation regulatory mechanisms

• Metabolic connections to cell cycle:

  • Analyze mitochondrial function throughout the cell cycle

  • Investigate potential metabolic checkpoint roles

  • Assess impact on energy production during key cell cycle transitions

  • Explore connection between mitochondrial NADH metabolism and cell cycle progression

• Integration with existing knowledge:

  • Compare phenotypic profiles with the 18 genes previously identified as negative regulators of mitotic entry

  • Investigate potential roles in parallel to known regulatory mechanisms

  • Explore connections to non-CDK Tyr15 phosphorylation-dependent mechanisms

  • Position within known stress response and cell geometry sensing pathways

This research direction builds on existing systematic screens of fission yeast that have revealed new elements acting at the G2/M cell cycle transition and could place SPAC227.03c within this regulatory network .